|
End-of-day quote
Dhaka S.E.
2026-09-03
|
5-day change | 1st Jan Change | ||
| 153.20 BDT | +3.51% |
|
+5.66% | +50.05% |
| 06-26 | Beximco suspension lifted; M1 payment date extension | AN |
| 06-24 | Beximco Pharmaceuticals PLC. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 555M | - | - | |||
| 1,024B | |||||
| 663B | - | - | - | ||
| 453B | |||||
| 352B | |||||
| 304B |
Select your edition
All financial news and data tailored to specific country editions
